HeimSHTDY • OTCMKTS
add
Sinopharm Group ADR
Við síðustu lokun
11,76 $
Dagbil
11,51 $ - 11,74 $
Árabil
10,13 $ - 16,31 $
Markaðsvirði
56,01 ma. HKD
Meðalmagn
26,45 þ.
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 141,66 ma. | -3,81% |
Rekstrarkostnaður | 6,72 ma. | -6,59% |
Nettótekjur | 1,46 ma. | 2,59% |
Hagnaðarhlutfall | 1,03 | 7,29% |
Hagnaður á hvern hlut | — | — |
EBITDA | 3,70 ma. | -5,19% |
Virkt skatthlutfall | 23,38% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 45,36 ma. | -32,44% |
Heildareignir | 415,08 ma. | — |
Heildarskuldir | 285,93 ma. | — |
Eigið fé alls | 129,16 ma. | — |
Útistandandi hlutabréf | 3,12 ma. | — |
Eiginfjárgengi | 0,46 | — |
Arðsemi eigna | 1,96% | — |
Ávöxtun eigin fjár | 3,85% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 1,46 ma. | 2,59% |
Handbært fé frá rekstri | -34,28 ma. | 27,81% |
Reiðufé frá fjárfestingum | 617,49 m. | 141,09% |
Reiðufé frá fjármögnun | 12,88 ma. | -41,88% |
Breyting á handbæru fé | -20,78 ma. | 17,10% |
Frjálst peningaflæði | -14,13 ma. | — |
Um
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Stofnsett
2003
Vefsvæði
Starfsfólk
108.217
